Anterior skull base malignant neoplasms are rare, accounting for less than 1% of all malignancies and 3 to 5% of head and neck cancers. However, they differ in their presentation, prognosis, and histopathology. In addition, they are often diagnosed at an advanced metastatic stage of the disease. Due to its rarity and wide range of presentation, there is no consensus on staging systems and treatment algorithms for anterior skull base malignancies. To get detailed insights into the “Treatment Strategies for Anterior Skull Base Malignancies,” join the proficient Head and Neck Surgical Oncologist, Dr.
Yogesh Dokhe , in our exclusive webinar on 4 th May 2026, 4:00 PM IST onwards . Stay Tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability,…
